Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.1. (Pharmacological Manipulation)

NCT05232032 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT05232032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05232032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.1. (Pharmacological Manipulation)
Lead sponsor
Mclean Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
February 1, 2025
Completion date
March 31, 2027
Enrollment
112 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorder, depressive disorder, major